Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 17:58
Grifols Market Cap: 6.487B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 6.164B |
| November 12, 2024 | 6.185B |
| November 11, 2024 | 6.334B |
| November 08, 2024 | 6.450B |
| November 07, 2024 | 6.456B |
| November 06, 2024 | 6.151B |
| November 05, 2024 | 6.314B |
| November 04, 2024 | 5.981B |
| November 01, 2024 | 6.008B |
| October 31, 2024 | 5.906B |
| October 30, 2024 | 5.960B |
| October 29, 2024 | 5.573B |
| October 28, 2024 | 5.668B |
| October 25, 2024 | 5.933B |
| October 24, 2024 | 6.022B |
| October 23, 2024 | 6.001B |
| October 22, 2024 | 5.994B |
| October 21, 2024 | 5.824B |
| October 18, 2024 | 5.879B |
| October 17, 2024 | 5.838B |
| October 16, 2024 | 5.770B |
| October 15, 2024 | 5.784B |
| October 14, 2024 | 5.831B |
| October 11, 2024 | 5.838B |
| October 10, 2024 | 5.865B |
| Date | Value |
|---|---|
| October 09, 2024 | 5.886B |
| October 08, 2024 | 5.954B |
| October 07, 2024 | 6.035B |
| October 04, 2024 | 6.062B |
| October 03, 2024 | 6.083B |
| October 02, 2024 | 6.008B |
| October 01, 2024 | 6.001B |
| September 30, 2024 | 6.035B |
| September 27, 2024 | 6.083B |
| September 26, 2024 | 5.974B |
| September 25, 2024 | 5.886B |
| September 24, 2024 | 5.913B |
| September 23, 2024 | 5.981B |
| September 20, 2024 | 6.083B |
| September 19, 2024 | 6.171B |
| September 18, 2024 | 5.940B |
| September 17, 2024 | 6.049B |
| September 16, 2024 | 6.280B |
| September 13, 2024 | 6.293B |
| September 12, 2024 | 6.191B |
| September 11, 2024 | 6.259B |
| September 10, 2024 | 5.716B |
| September 09, 2024 | 5.824B |
| September 06, 2024 | 5.770B |
| September 05, 2024 | 6.035B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.715B
Minimum
Mar 06 2024
17.53B
Maximum
Feb 21 2020
8.699B
Average
7.504B
Median
Jan 02 2024
Market Cap Benchmarks
| Cellectis SA | 190.18M |
| Adaptimmune Therapeutics PLC | 150.89M |
| Akari Therapeutics PLC | 26.78M |
| Biodexa Pharmaceuticals PLC | 2.799M |
| Verona Pharma PLC | 2.893B |
Market Cap Related Metrics
| PE Ratio | 30.08 |
| PS Ratio | 0.8758 |
| PEG Ratio | 6.599 |
| Price to Book Value | 1.086 |
| Price | 9.545 |
| Earnings Yield | 3.32% |
| PEGY Ratio | 6.599 |
| Operating PE Ratio | 5.702 |
| Normalized PE Ratio | 27.45 |